Search
In the afternoon, AI medical stocks exhibited volatility followed by a surge. Notably, RDI Medical hit its daily limit, with other stocks such as Hongbo Pharmaceutical, Kailer Stocks, Chuangye Huikang, Wining Health, and Thalys Medical closely following suit in their upward trajectory. The impetus behind this rally stems from the "Implementation Plan for the Digital and Intelligent Transformation of the Pharmaceutical Industry" jointly issued by seven departments. This ambitious plan aims to achieve comprehensive digital and intelligent transformation of pharmaceutical enterprises above a certain size by 2030, thereby accelerating the progression of AI pharmaceuticals. Cinda Securities anticipates that 2025 will mark the inaugural year of rapid development for AI medical care.
-
C114 Communication Network -
Communication Home
